Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2654 | 2109 | 41.3 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RET PTC | Author keyword | 58 | 68% | 2% | 51 |
2 | PAPILLARY THYROID CARCINOMA | Author keyword | 56 | 23% | 10% | 216 |
3 | HBME 1 | Author keyword | 38 | 59% | 2% | 42 |
4 | PAX8 PPAR GAMMA | Author keyword | 26 | 100% | 1% | 11 |
5 | BRAFV600E MUTATION | Author keyword | 26 | 68% | 1% | 23 |
6 | RET PTC1 | Author keyword | 23 | 86% | 1% | 12 |
7 | BRAF MUTATION | Author keyword | 23 | 31% | 3% | 63 |
8 | FOLLICULAR VARIANT | Author keyword | 15 | 53% | 1% | 20 |
9 | PAPILLARY CARCINOMA | Author keyword | 15 | 15% | 4% | 94 |
10 | RET PTC ONCOGENE | Author keyword | 14 | 100% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RET PTC | 58 | 68% | 2% | 51 | Search RET+PTC | Search RET+PTC |
2 | PAPILLARY THYROID CARCINOMA | 56 | 23% | 10% | 216 | Search PAPILLARY+THYROID+CARCINOMA | Search PAPILLARY+THYROID+CARCINOMA |
3 | HBME 1 | 38 | 59% | 2% | 42 | Search HBME+1 | Search HBME+1 |
4 | PAX8 PPAR GAMMA | 26 | 100% | 1% | 11 | Search PAX8+PPAR+GAMMA | Search PAX8+PPAR+GAMMA |
5 | BRAFV600E MUTATION | 26 | 68% | 1% | 23 | Search BRAFV600E+MUTATION | Search BRAFV600E+MUTATION |
6 | RET PTC1 | 23 | 86% | 1% | 12 | Search RET+PTC1 | Search RET+PTC1 |
7 | BRAF MUTATION | 23 | 31% | 3% | 63 | Search BRAF+MUTATION | Search BRAF+MUTATION |
8 | FOLLICULAR VARIANT | 15 | 53% | 1% | 20 | Search FOLLICULAR+VARIANT | Search FOLLICULAR+VARIANT |
9 | PAPILLARY CARCINOMA | 15 | 15% | 4% | 94 | Search PAPILLARY+CARCINOMA | Search PAPILLARY+CARCINOMA |
10 | RET PTC ONCOGENE | 14 | 100% | 0% | 7 | Search RET+PTC+ONCOGENE | Search RET+PTC+ONCOGENE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PAPILLARY CARCINOMAS | 243 | 66% | 11% | 224 |
2 | BRAFV600E MUTATION | 221 | 70% | 9% | 181 |
3 | PAX8 PPAR GAMMA REARRANGEMENT | 163 | 90% | 3% | 71 |
4 | RET PTC REARRANGEMENTS | 109 | 70% | 4% | 90 |
5 | POORLY DIFFERENTIATED CARCINOMAS | 77 | 80% | 2% | 48 |
6 | FOLLICULAR VARIANT | 73 | 47% | 5% | 115 |
7 | RET PTC | 49 | 64% | 2% | 47 |
8 | BRAF V600E MUTATION | 42 | 35% | 5% | 98 |
9 | RET PTC REARRANGEMENT | 41 | 85% | 1% | 22 |
10 | PREVALENT AREA | 41 | 100% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Molecular pathogenesis and mechanisms of thyroid cancer | 2013 | 110 | 199 | 61% |
Molecular genetics and diagnosis of thyroid cancer | 2011 | 167 | 185 | 79% |
BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications | 2007 | 350 | 163 | 54% |
Molecular Diagnostics and Predictors in Thyroid Cancer | 2009 | 123 | 104 | 91% |
BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review | 2015 | 1 | 52 | 96% |
BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment A Systematic Review and Meta-Analysis | 2012 | 54 | 80 | 73% |
BRAF mutation in thyroid cancer | 2005 | 489 | 108 | 54% |
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis | 2008 | 115 | 121 | 79% |
Pathogenetic mechanisms in thyroid follicular-cell neoplasia | 2006 | 385 | 214 | 44% |
An update on molecular biology of thyroid cancers | 2014 | 11 | 233 | 61% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELLULAR MOL THYROID | 13 | 58% | 0.7% | 15 |
2 | CANC BIOL ANGIOGENESIS PATHOL | 6 | 80% | 0.2% | 4 |
3 | MICROBIOL IMMUNOL OTOLARYNGOL HEAD NECK | 6 | 100% | 0.2% | 4 |
4 | BASIC CLIN IMMUNOL SCI | 4 | 75% | 0.1% | 3 |
5 | GENET BASES THYROID TUMOR | 4 | 46% | 0.3% | 6 |
6 | ENDOCRINE SURG ONCOL PROGRAM | 3 | 100% | 0.1% | 3 |
7 | ENDOCRINE SURG UNITTHYROID CANC | 3 | 100% | 0.1% | 3 |
8 | SEZ MISEM | 3 | 100% | 0.1% | 3 |
9 | AGOSTINO GEMELLI MED | 3 | 31% | 0.4% | 8 |
10 | JB PIERCE | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000234459 | INSULAR CARCINOMA//COLUMNAR CELL CARCINOMA//HURTHLE CELL CARCINOMA |
2 | 0.0000221566 | ANAPLASTIC THYROID CANCER//ANAPLASTIC THYROID CARCINOMA//LENVATINIB |
3 | 0.0000165341 | CHRONIC LYMPHOCYTIC THYROIDITIS//LYMPHOCYTIC THYROIDITIS//ADVANCED TUMOR STAGE |
4 | 0.0000145838 | THYROID NODULE//THYROID NODULES//FOLLICULAR NEOPLASM |
5 | 0.0000111535 | FAMILIAL NON MEDULLARY THYROID CANCER//FAMILIAL THYROID CARCINOMA//CANC MOL GENET GEMOCA |
6 | 0.0000091913 | DIFFERENTIATED THYROID CANCER//THYROGLOBULIN//DIFFERENTIATED THYROID CARCINOMA |
7 | 0.0000084509 | CHERNOBYL//PEDIATRIC THYROID CANCER//CHERNOBYL NUCLEAR ACCIDENT |
8 | 0.0000083756 | SODIUM IODIDE SYMPORTER//SODIUM IODIDE SYMPORTER NIS//IODIDE TRANSPORT |
9 | 0.0000077426 | IODOLIPIDS//FRTL 5 CELLS//NON AUTOIMMUNE HYPERTHYROIDISM |
10 | 0.0000073915 | MEDULLARY THYROID CARCINOMA//RET PROTO ONCOGENE//MEDULLARY THYROID CANCER |